TNF-α receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 443-451

  Minter, Rebecca M ^a   Rectenwald, John E ^a   Fukuzuka, Kunitaro ^a   Tannahill, Cynthia L ^a   La Face, Drake ^a   Tsai, Van ^a   Ahmed, Iqbal ^a   Hutchins, Elizabeth ^a   Moyer, Richard ^b   Copeland III, Edward M ^a   Moldawer, Lyle L ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDE; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE REPRESSION; GENE TARGETING; GENE THERAPY; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOREGULATION; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; TRANSGENE; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

EID: 18744436532     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.443     Document Type: Article

References (48)

1. Brody, S. L., and R. G. Crystal. 1994. Adenovirus-mediated in vivo gene transfer. Ann. NY Acad. Sci. 716:90.
2. Robbins, P. D., and S. C. Ghivizzani. 1998. Viral vectors for gene therapy. Pharmacol. Ther. 80:35.
3. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890.
4. Yang, Y., Z. Xiang, H. C. Ertl, and J. M. Wilson. 1995. Up-regulation of class 1 major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad Sci. USA 92:7257.
5. Worgall, S., G. Wolff, E. Falck-Pedersen, and R. G. Crystal. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8:37.
6. Wohlfart, C. 1988. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J. Virol. 62:2321.
7. Yang, Y., Q. Su, and J. M. Wilson. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:7209.
8. Christ, M., M. Lusky, F. Stoeckel, D. Dreyer, A. Dieterle, A. I. Michuo, A. Pavirani, and M. Mehtali. 1997. Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response, Immunol. Lett. 57:19.
9. Kolls, J. K., D. Lei, G. Odom, S. Nelson, W. R. Summer, M. A. Gerber, and J. E. Shellito. 1996. Use of transient CD4 lymphocyte depletion to prolong transgene expression of El-deleted adenoviral vectors. Hum. Gene Ther. 7:489.
10. Vilquin, J. T., B. Guerette, I. Kinoshita, B. Roy, M. Goulet, C. Gravel, R. Roy, and J. P. Tremblay. 1995. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6:1391.
11. + CTLs in vivo. J. Immunol. 155:2564.
12. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
13. Elkon, K. B., C. C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. A. Abrahamsen, X. Song, J. L. Zhou, L. J. Old, R. G. Crystal, and E. Falck-Pedersen. 1997. Tumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. acad. Sci. USA 94:9814.
14. Zhang, H. G., T. Zhou, P. Yang, C. K. Edwards, D. T. Curiel, and J. D. Mountz. 1998. Inhibition of tumor necrosis factor α decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum. Gene Ther. 9:1875.
15. Benihoud, K., I. Saggio, P. Opolon, B. Salone, F, Amiot, E. Connault, C. Chianale, F. Dautry, P. Yeh, and M. Perricaudet. 1998. Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor a and lymphotoxin α. J. Virol. 72:9514.
16. Ksontini, R., S. L. MacKay, and L. L. Moldawer. 1998. Revisiting the role of tumor necrosis factor α and the response to surgical injury and inflammation. Arch. Surg, 133:558.
17. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. J. Palladino. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637.
18. Welborn, M. B., Z. K. Van, P. D. Edwards, J. H. Pruitt, A. Kaibara, J. N. Vauthey, M. Rogy, W. L. Castleman, S. F. Lowry, and J. S. Kenney. 1996. A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation hut does not produce inflammation or shock in the baboon. J. Exp. Med. 184:165.
19. De Waal, M. R., J. Haanen, H. Spits, M. G. Roncarolo, V. A. Te, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and V. J. De. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
20. Taga, K., and G. Tosato. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143.
21. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
22. Ralph, P., I. Nakoinz, A. Sampson-Johannes, S. Fong, D. Lowe, H. Y. Min, and L. Lin. 1992. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol. 148:808.
23. Cassatella, M. A., L. Meda, S. Bonora, M. Ceska, and G. Constantin. 1993. Interleukin 10 (IL-10) inhibits the release of proinflammatory cylokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1 β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207.
24. Ding, L., and E. M. Shevach. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:3133.
25. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 151:2390.
26. Smith, R. C., K. N. Wills, D. Antelman, H. Perlman, L. N. Truong, K. Krasinski, and K. Walsh. 1997. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation 96:1899.
27. Wills, K. N., D. C. Maneval, P. Menzel, M. P. Harris, S. Sutjipto, M. T. Vaillancourt, W. M. Huang, D. E. Johnson, S. C. Anderson, and S. F. Wen. 1994. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther. 5:1079.
28. Graham, F. L., and L. Prevec. 1995. Methods for construction of adenovirus vectors. Mol. Biotechnol. 3:207.
29. Vieira, P., R. de Waal-Malefyt, M. N. Dang, K. E. Johnson, R. Kastelein, D. F. Fiorentino, J. E. deVries, M. G. Roncarolo, T. R. Mosmann, and K. W. Moore. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl. Acad. Sci. USA 88:1172.
30. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEH1 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
31. Welborn, M. B., W. G. Douglas, Z. Abouhamze, T. Auffenberg, A. S. Abouhamze, J. Baumhofer, J. M. Seeger, J. H. Pruitt, P. D. Edwards, R. Chizzonite, et al. 1996. Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse. Shock 6:171.
32. Ksontini, R., D. B. Colagiovanni, M. D. Josephs, C. K. Edwards, C. L. Tannahill, C. C. Solorzano, J. Norman, W. Denham, M. Clare-Salzler, S. L. MacKay, and L. L. Moldawer. 1998. Disparate roles for TNF-α and Fas ligand in concanavalin A-induced hepatitis. J. Immunol 160:4082.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
34. Solorzano, C. C., A. Kaibara, P. J. Hess, P. D. Edwards, R. Ksontini, A. Abouhamze, S. McDaniel, J. Frazier, D. Trujillo, G. Kieft, et al. 1998. Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR hinding proteins in healthy and bacteremic baboon. J. Appl. Physiol 84:1119.
35. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Prof. Natl. Acad. Sci. USA 88: 1651.
36. Shears, L. L., M. R. Kibbe, A. D. Murdock, T. R. Billiar, A. Lizonova, I. Kovesdi, S. C. Watkins, and E. Tzeng. 1998. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J. Am. Coll. Surg. 187:295.
37. Yamasaki, K., H. D. Edington, C. McClosky, E. Tzeng, A. Lizonova, I. Kovesdi, D. L. Steed, and T. R. Billiar. 1998. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invent. 101:967.
38. Qin, L., Y, Ding, D. R. Pahud, N. D. Robson, A. Shaked, and J. S. Bromberg. 1997. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8:1365.
39. Siders, W. M., P. W. Wright, J. A. Hixon, W. G. Alvord, T. C. Baek, R. H. Wiltrout, and R. G. Fenton. 1998. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus, J. Immunol. 160:5465.
40. Apparailly, F., C. Verwaerde, C. Jacquet, C. Auriault, J. Sany, and C. Jorgensen. 1998. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160:5213.
41. Le, C. H., A. G. Nicolson, A. Morales, and K. L. Sewell. 1997. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor α receptor gene. Arthritis Rheum. 40:1662.
42. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R. A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70:6370.
43. Worgall, S., P. L. Leopold, G. Wolff, B. Ferris, R. N. Van, and R. G. Crystal. 1997. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum. Gene Ther. 8:1675.
44. Douni, E., and G. Kollias. 1998. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF. lymphotoxin α. or the p55TNF-R. J. Exp. Med. 188:1343.
45. Qin, L., Y. Ding, D. R. Pahud, N. D. Robson, A. Shaked, and J. S. Bromberg. 1997. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8: 1365.
46. Carson, W. E., M. J. Lindemann, R. Baiocchi, M. Linett, J. C. Tan, C. C. Chou, S. Narula, and M. A. Caligiuri. 1995. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85:3577.
47. Berman, R. M., T. Suzuki, H, Tahara, P. D. Robbins, S. K. Narula, and M. T. Lotze. 1996. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice J. Immunol 157:231.
48. David, A., H. Coupel-Clauce, J. Chetritt, L. Tesson, A. Cassard, B. Chaneau, J. P. Soulillou, and I. Anegon. 1998. Anti-adenovirus immune responses in rats are enhanced by interleukin 4 but not interleukin 10 produced by recombinant adenovirus. Hum. Gene Ther. 9:1755.